Cour Pharma-preview

Cour

Cour Pharma

Private

Skokie, IllinoisHealthcare & Life Scienceshttps://www.courpharma.com

Last Round

Series A

Jan 30, 2024

Total Funding Raised

$105M

Company Overview

Cour is a biotechnology company focused on developing an immune-modifying platform that provides non-biological therapeutics for acute inflammation, autoimmunity, and allergic conditions, while also advancing pharmaceutical solutions for immunology, pathology, and cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

antigen-specific immune tolerancenanoparticle platformautoimmune disease therapytolerogenic therapyimmune reprogrammingnanoparticle therapeuticsnanomedicinedisease-modifying therapyCeliac DiseaseType 1 Diabetesbiotech licensingclinical-stage biotechMyasthenia Gravispharma partnershipsPrimary Biliary Cholangitis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cour Pharma Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cour Pharma Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jan 30, 2024
VC Round	Sep 7, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Brian Bock

CFO

Executive Team

Cour Pharma Investors

Notable investors and investment history

Investor	Rounds
Alpha Wave Ventures	VC Round, Series A
Roche Venture Fund	Series A
Angelini Ventures	Series A
Lumira Ventures	Series A
T1D Fund	Series A
Pfizer	Series A
Chimera Capital Management	Series A

View all Investors

Cour Pharma Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cour Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cour Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSkokie, Illinois

Employee Range78

Year Founded2013

Last FundingJan 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.